Cargando…

Adverse events of inactivated COVID-19 vaccine in HIV-infected adults

This study aims to evaluate the safety of inactivated COVID-19 vaccine among adult people living with HIV (PLWH). In total, 259 PLWH who received at least one dose of inactivated COVID-19 vaccine were enrolled, and post-vaccination adverse events (AEs) were evaluated seven days following each vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Songjie, Zhang, Yubin, Ming, Fangzhao, Zou, Shi, Wu, Mengmeng, Guo, Wei, Tang, Weiming, Liang, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643182/ https://www.ncbi.nlm.nih.gov/pubmed/34863210 http://dx.doi.org/10.1186/s12981-021-00416-1

Ejemplares similares

Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
por: Zou, Shi, et al.
Publicado: (2022)

A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines
por: Tan, Yuting, et al.
Publicado: (2023)

Humoral Immune Response to Inactivated COVID-19 Vaccination at the 3rd Month among People Living with HIV
por: Wu, Songjie, et al.
Publicado: (2022)

Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV
por: Wu, Songjie, et al.
Publicado: (2023)

Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals
por: Zou, Shi, et al.
Publicado: (2022)

Distinct Infection Forms of SARS-CoV-2 Among People Living With HIV
por: Wu, Mengmeng, et al.
Publicado: (2021)

Risk of SARS-CoV-2 Infection Among People Living With HIV in Wuhan, China
por: Wu, Mengmeng, et al.
Publicado: (2022)

Are people living with HIV have a low vulnerability to omicron variant infection: results from a cross-sectional study in China
por: Tan, Yuting, et al.
Publicado: (2023)

People Living with HIV Easily lose their Immune Response to SARS-CoV-2: Result From A Cohort of COVID-19 Cases in Wuhan, China
por: Liu, Yanbin, et al.
Publicado: (2021)

People living with HIV easily lose their immune response to SARS-CoV-2: result from a cohort of COVID-19 cases in Wuhan, China
por: Liu, Yanbin, et al.
Publicado: (2021)

COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China
por: Wu, Songjie, et al.
Publicado: (2022)

Ocular Adverse Events after Inactivated COVID-19 Vaccination
por: Li, Zhihua, et al.
Publicado: (2022)

Safety of Inactivated SARS-CoV-2 Vaccines Among Adults with Experience of Allergies to Food or Medicines
por: Jin, Yan, et al.
Publicado: (2023)

Adverse pregnancy outcomes associated with antiretroviral therapy initiated before pregnancy and during pregnancy: a retrospective study in Hubei province, China
por: Tan, Yuting, et al.
Publicado: (2023)

Vaccine Adverse Events Following COVID-19 Vaccination with Inactivated Vaccines in Zimbabwe
por: Makadzange, Azure Tariro, et al.
Publicado: (2022)

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals
por: Li, Juan, et al.
Publicado: (2021)

Patterns of HIV and SARS‐CoV‐2 co‐infection in Wuhan, China
por: Guo, Wei, et al.
Publicado: (2020)

Ocular Adverse Events after Inactivated COVID-19 Vaccination in Xiamen
por: Chen, Xiuju, et al.
Publicado: (2022)

Adverse Drug Events Monitoring of Live Attenuated Pandemic Influenza Vaccine
por: Akat, Pramod B, et al.
Publicado: (2011)

The Diagnostic Trap Occurred in Two COVID-19 Cases Combined Pneumocystis Pneumonia in Patient with AIDS
por: Guo, Wei, et al.
Publicado: (2020)

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
por: Kato, Yamato, et al.
Publicado: (2015)

Safety of inactivated COVID-19 vaccine in tuberous sclerosis complex patients with epilepsy treated with rapamycin
por: Lu, Qian, et al.
Publicado: (2022)

Impact of various vaccine boosters on neutralization against omicron following prime vaccinations with inactivated or adenovirus-vectored vaccine
por: Huang, Qingrui, et al.
Publicado: (2022)

Driving Force of Covid-19 Among People Living With HIV/AIDS in Wuhan, China
por: Guo, Wei, et al.
Publicado: (2020)

The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
por: Zhu, Weijun, et al.
Publicado: (2015)

Safety and Adverse Events Related to Inactivated COVID-19 Vaccines and Novavax;a Systematic Review
por: Dadras, Omid, et al.
Publicado: (2022)

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
por: Duprey, Matthew S., et al.
Publicado: (2019)

Surveillance of Vaccination Coverage of Inactivated Influenza Vaccines and Allergic Rash Adverse Events Following Immunization for Children From 6 Manufacturers
por: Li, Zhi-qun, et al.
Publicado: (2023)

Willingness to receive the COVID-19 vaccine among HIV positive men who have sex with men in China: a cross-sectional study
por: Wu, Songjie, et al.
Publicado: (2023)

Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)
por: Welsh, Kerry J., et al.
Publicado: (2021)

Management of adverse events related to checkpoint inhibition therapy
por: Rudzki, Jakob Daniel
Publicado: (2018)

Medical adverse events in the US 2018 mortality data
por: Oura, Petteri
Publicado: (2021)

A comparison of nurses’ and physicians’ perception of cancer treatment burden based on reported adverse events
por: Lee, Shing M., et al.
Publicado: (2019)

Microbiomes Detected by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing among HIV-Infected and Uninfected Patients with Pulmonary Infection
por: Tan, Yuting, et al.
Publicado: (2023)

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study
por: Hu, Yuemei, et al.
Publicado: (2019)

Evaluation of the humoral immune responses in adult cattle and sheep, 4 and 2.5 years post-vaccination with a bluetongue serotype 8 inactivated vaccine()
por: Batten, C.A., et al.
Publicado: (2013)

Introducing seasonal influenza vaccine in low-income countries: an adverse events following immunization survey in the Lao People's Democratic Republic
por: Phengxay, Manilay, et al.
Publicado: (2015)

The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys
por: Muraki, Yuko, et al.
Publicado: (2015)

Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine
por: Kanokudom, Sitthichai, et al.
Publicado: (2022)

Acute adverse events of Sars-CoV2 vaccines: Experiences from a health care worker vaccination campaign in two municipal hospitals in northwest Germany
por: Kermer, Pawel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cjj806gg76b01b35q54n98hhas